About
Yuri Deigin is a biotech entrepreneur and longevity-sector operator best known as co-founder and CEO of YouthBio Therapeutics, a company developing partial cellular reprogramming gene therapies for age-related disease, especially Alzheimer's. Public company materials describe him as having more than 15 years of drug discovery and development experience and as a vocal advocate of epigenetic rejuvenation since 2017. He holds an MBA from Columbia Business School and a BSc from the University of Toronto.
Areas of interest
longevitybiotechgene therapypartial cellular reprogrammingepigenetic rejuvenationAlzheimer's diseaseneurodegenerationaging biologycryonicsbioethicscodingcomplexity theoryquantum computationphysicsspace explorationfinanceeconomicsstock market